SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-017879
Filing Date
2023-05-04
Accepted
2023-05-04 16:16:24
Documents
75
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-20230331.htm   iXBRL 10-Q 2998938
2 EX-31.1 mirm-ex31_1.htm EX-31 21306
3 EX-32.1 mirm-ex32_1.htm EX-32 12092
  Complete submission text file 0000950170-23-017879.txt   11780845

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mirm-20230331_cal.xml EX-101.CAL 57971
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mirm-20230331_def.xml EX-101.DEF 328308
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mirm-20230331_lab.xml EX-101.LAB 663568
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mirm-20230331_pre.xml EX-101.PRE 498343
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mirm-20230331.xsd EX-101.SCH 84515
69 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20230331_htm.xml XML 2307056
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 23888975
SIC: 2834 Pharmaceutical Preparations